// App-Quantinova.ai

: Correlation of the immune tumor microenvironment (I-TME) with gene expression profiles as prognostic and predictive factors in patients (pts) with metastatic renal carcinoma (mRCC) treated with immunotherapy (Meet-URO 18 I-TME study).

Researchers

Presenter

  • Fabio Catalano

Principal Investigators

  • Sara Elena Rebuzzi

  • Francesca Galuppini

  • Sebastiano Buti

  • Matteo Brunelli

  • Marco Maruzzo

  • Angelo Paolo Dei Tos

  • Umberto Basso

  • Giuseppe Lugi Banna

  • Alessio Signori

  • Marta Sbaraglia

  • Alessandra Damassi

  • Malvina Cremante

  • Silvia Puglisi

  • Annalice Gandini

  • Marta Rebuzzi

  • Alessandra Mosca

  • Giuseppe Fornarini

  • Pasquale Rescigno

Medical Centers

  • Medical Oncology, Ospedale San Paolo, Milan, Italy

  • Medical Oncology, Candiolo Cancer Institute-FPO-IRCCS, Candiolo, Italy

  • Candiolo Cancer Institue - FPO, IRCCS, Turin, Italy

  • Department of Medicine and Surgery, University of Salerno, Salerno, Italy

  • Medical Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy

  • Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, Italy, Rome, Italy

  • Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

  • Surgical Pathology Unit, Department of Medicine (DIMED) University of Padua, Italy, Padova, Italy

  • Department of Health Sciences (DISSAL), Section of Biostatistics, University of Genoa, Genoa, Italy

  • Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova, Genova

  • Department of Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom

  • Department of Diagnostics and Public Health, Section of Pathological Anatomy, University of Verona, Verona, Italy

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Renal cell carcinoma

  • Metastatic Renal Cell Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved